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ABSTRACT
The Xylitol for Adult Caries Trial was a three-year, 
double-blind, multi-center, randomized clinical 
trial that evaluated the effectiveness of xylitol vs. 
placebo lozenges in the prevention of dental caries 
in caries-active adults. The purpose of this second-
ary analysis was to investigate whether xylitol 
lozenges had a differential effect on cumulative 
caries increments on different tooth surfaces. 
Participants (ages 21-80 yrs) with at least one 
follow-up visit (n = 620) were examined at base-
line, 12, 24, and 33 months. Negative binomial and 
zero-inflated negative binomial regression models 
were used to estimate incidence rate ratios (IRR) 
for xylitol’s differential effect on cumulative caries 
increments on root and coronal surfaces and, 
among coronal surfaces, on smooth (buccal and 
lingual), occlusal, and proximal surfaces. 
Participants in the xylitol arm developed 40% 
fewer root caries lesions (0.23 D2FS/year) than 
those in the placebo arm (0.38 D2FS/year; IRR = 
0.60; 95% CI [0.44, 0.81]; p < .001). There was no 
statistically significant difference between xylitol 
and control participants in the incidence of smooth-
surface caries (p = .100), occlusal-surface caries 
(p = .408), or proximal-surface caries (p = .159). 
Among these caries-active adults, xylitol appears 
to have a caries-preventive effect on root surfaces 
(ClinicalTrials.gov NCT00393055).
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Dental caries results from an imbalance of demineralization and reminer-alization processes at the tooth-biofilm interface over time (Featherstone, 
2004). These processes are modulated by modifying factors such as biofilm 
composition and pH, Ca and PO4 saturation in and buffer capacity of saliva, 
use (frequency and type) of fluoride and other caries-preventive agents, 
oral hygiene, diet, and tooth anatomy (Dawes, 2003; Khoo et al., 2005; 
Featherstone, 2008). Relative to the latter, conditions for demineralization-
remineralization dynamics can be affected by specific ecological factors that 
characterize different tooth surfaces. For example, occlusal surfaces in pos-
terior teeth have a different susceptibility to biofilm attachment (and possi-
bly different biofilm composition and virulence) than do buccal surfaces in 
anterior teeth (Huang et al., 2011; Seneviratne et al., 2011). Smooth (buccal 
and lingual) coronal and root surfaces are more readily exposed to saliva’s 
remineralizing potential than are proximal surfaces and occlusal fissures. 
Additionally, because the critical pH for demineralization is higher for dentin 
than it is for enamel (Fejerskov and Kidd, 2008), root surfaces are considered 
to be at a higher caries risk than coronal surfaces (McIntyre et al., 2000). 
Therefore, when one is studying the effectiveness of interventions on caries 
prevention, it is important to examine their effects on these different tooth 
surfaces as a whole as well as separately (McDonald and Sheiham, 1992).
The Xylitol for Adult Caries Trial (X-ACT) was a three-year, placebo- 
controlled, double-blind, multi-center, randomized clinical trial that evaluated 
the effectiveness of xylitol lozenges in the prevention of dental caries in 
caries-active adults (Bader et al., 2010). The principal results of the X-ACT 
trial showed that daily use of 3 to 5 grams of xylitol did not result in a statis-
tically significant reduction in overall caries increment when compared with 
use of a placebo (Bader et al., 2013). However, for the reasons discussed 
above, it is conceivable that xylitol may have different caries-preventive 
effects on various tooth surfaces.
The purpose of this study was to compare the caries-preventive effects of 
xylitol (1) on root and coronal surfaces and (2) among coronal surfaces, on 
smooth (buccal and lingual), occlusal, and proximal surfaces.
MATERIALS & METHODS
Study Design
The X-ACT study design has been described in detail elsewhere (Bader et al., 
2010) and is summarized here. In total, 681 participants were randomized at 
3 study clinical sites: The University of Alabama at Birmingham (UAB), The 
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University of North Carolina at Chapel Hill (UNC), and The 
University of Texas Health Sciences Center at San Antonio 
(UTHSCSA). The Kaiser Permanente Center for Health 
Research (Portland, OR) served as the Data Coordinating 
Center. Institutional Review Boards at each clinical site approved 
the study, and all participants provided informed consent.
Recruitment, Inclusion and Exclusion Criteria
We recruited participants from dental school clinics, community 
dental clinics, and the general community. To be eligible, par-
ticipants had to be aged 21 to 80 yrs, have at least 12 teeth with 
exposed dental surfaces, and have one or more coronal or root 
caries lesions either at the time of the baseline examination or 
documented within the preceding 12 mos. Exclusion criteria 
included the presence of more than 10 teeth with caries lesions, 
history of head and neck radiation, history of receiving long-
term antibiotic therapy, and allergy to xylitol or other mint 
components. Following a 4-week run-in period (with placebo 
lozenges), eligible participants were randomized to receive xyli-
tol or placebo lozenges. For the secondary analysis reported 
here, only participants with at least one follow-up visit and 
complete data on all covariates (n = 620, 91% of the 681 ran-
domized participants) were included. This strategy avoided the 
inclusion of participants with questionable adherence data from 
one study site, as reported in the main outcomes paper (Bader 
et al., 2013). Data for all randomized participants are available 
at http://www.xactstudy.org.
Study Procedures
Participants received a caries examination at baseline and were 
scheduled to return yearly for three follow-up caries examina-
tions. Before the 24-month visits began, the final examination 
schedule was shifted to 33 mos to adjust for slower-than-
expected enrollment.
Study Treatments
The intervention consisted of 5 lozenges spaced across the day 
and dissolved in the mouth. The active lozenge contained 1.0 g 
of xylitol as a sweetening agent (other ingredients: polydex-
trose, magnesium stearate, and natural flavors). The placebo 
lozenge was identical to the active lozenge but was sweetened 
with sucralose. Both lozenges were supplied by Fennobon Oy 
(Karkkila, Finland).
Oral Examination
Caries examinations were completed at baseline, 12, 24, and 
33 mos. To the extent possible, the follow-up examinations were 
performed by the same examiner who conducted the baseline 
examination. Examiners were trained and certified at the outset 
of recruitment and roughly annually thereafter (Banting et al., 
2011). They also completed second examinations of approxi-
mately 5% of participants annually to determine intra-examiner 
reliability. Examiners used a dental mirror and a Community 
Periodontal Index of Treatment Needs (CPITN) dental probe. 
Magnifying loupes were used at the discretion of the examiner, 
but consistently throughout the trial. Radiographs were not 
used. With the help of a trained study recorder, examiners 
recorded coronal and root surfaces as either missing, sound, 
carious, restored (filled or crowned), or sealed, as well as sur-
faces that were unable to be scored. Root surfaces were ana-
tomically defined as those surfaces apical to the cemento-enamel 
junction (CEJ).
Tooth surfaces were dried for 5 sec with an air/water syringe. 
Examiners used a modification of the International Caries 
Detection and Assessment System (ICDAS II) (Ismail et al., 
2007) with 4 disease levels possible for each coronal surface 
[sound (S), non-cavitated enamel lesion (D1), cavitated lesion 
penetrating the enamel (D2), and cavitated lesion penetrating the 
dentin, or “shadowing” (D3)] and 3 disease levels possible for 
each root surface [sound (S), non-cavitated root lesion (D1), or 
cavitated root lesion (D2)]. Restored surfaces were noted as 
filled (F) or crowned (C), and pit-and-fissure sealants (P) were 
noted as sound. In addition, D3 lesions were grouped with D2 
lesions (and are hereafter described as D2FS), and lesions adja-
cent to coronal or root restorations, crowns, and pit-and-fissure 
sealants were noted as such.
The mean intra-examiner reliability values (unweighted 
kappa, D2D3 vs. all else) for primary examiners combined were 
0.58, 0.88, 0.67, and 0.71 for the baseline and 12-, 24-, and 
33-month examinations, respectively (Bader et al., 2013).
Questionnaire Data
Participants completed a series of baseline and annual question-
naires that included information on demographics (including, 
age, gender, and race), medical history, and dental and oral 
health. Relevant questionnaire items considered for this second-
ary analysis included participants’ age, dental visit history, 
brushing/flossing frequency, and over-the-counter fluoride 
exposure (use of fluoridated toothpaste and fluoridated mouth-
wash after brushing). Complete questionnaire items are avail-
able at http://www.xactstudy.org.
Statistical Analyses
The primary outcome variable for the main X-ACT trial was the 
annualized D23FS (cavitated caries lesions) caries increment for 
combined root and coronal surfaces, computed as the weighted 
sum of changes (transitions) in tooth-surface status (Bader et al., 
2010). Reversals were considered invalid transitions and scored 
0. Null transitions (e.g., F to F), transitions from D2 to treated 
status (F or C), or to or from an unscorable status (e.g., missing 
surfaces) were also scored 0. In the secondary analysis reported 
here, we conducted separate analyses for root and coronal sur-
faces and, among the latter, for smooth (buccal and lingual), 
occlusal, and proximal surfaces.
Consistent with the trial’s primary outcome analysis, we used 
negative binomial (NB) regression to model the coronal incre-
ment scores. However, given the large number of zero incre-
ments for root surfaces, we used zero-inflated negative binomial 
(ZINB) regression to model the root increment scores (Preisser 
et al., 2012). Treatment was included in the log rate part of the 
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ZINB model, but not in the logistic part (because it was believed 
that treatment would not affect zero-inflation). As a result, both 
the NB and ZINB models give rise to incidence rate ratios (IRR), 
representing overall effects for comparing the effect of xylitol vs. 
placebo lozenges on annualized mean caries increments. For both 
the NB and ZINB models, we included dental visit history, over-
the-counter (OTC) fluoride exposure from toothpaste, mouth-
wash, or both, brushing/flossing habits, clinical site, and age as 
covariates and duration of follow-up as a model offset. For the 
coronal surfaces, we also assessed treatment by surface type inter-
action in a multivariate model, to test whether the effect of treat-
ment varied across the different types of coronal surfaces. These 
analyses adjusted the standard errors to account for the intraclass 
correlation of the D2FS indices within participants using the clus-
tered empirical sandwich estimator.
Finally, we also examined whether any ‘treatment by surface 
type’ effects differed by clinical site by examining whether the 
‘clinical site by treatment’ (for root and coronal surface analy-
ses) or the ‘clinical site by treatment by surface type’ (proximal, 
occlusal, and smooth coronal surface analysis) interactions were 
significant.
We used a two-tailed alpha of 0.05 to define statistical signifi-
cance and conducted analyses using a combination of both SAS 
9.2 (Cary, NC, USA) and Stata 11.2 (College Station, TX, USA).
RESULTS
Among the 620 participants included in this secondary analysis, 
308 were randomized to the xylitol arm and 312 to the placebo 
arm. Mean duration of follow-up was 2.61 yrs, and loss to 
follow-up was balanced between study arms. Mean age was 
47.3 yrs (range, 21-80 yrs), and 65% were women (Table 1). The 
majority brushed at least twice/day and were exposed to fluoride 
through office visits or toothpaste, or both (communities in all 3 
clinical sites have fluoridated municipal water). Very few 
reported having dry mouth. We observed similar participant 
characteristics across the clinical sites.
Xylitol’s effects on root and coronal caries increments, as 
well as for each coronal surface type, are presented in Table 2. 
Participants in the xylitol arm developed 40% fewer root caries 
lesions than those in the placebo arm (0.23 vs. 0.38 D2FS/yr; 
IRR = 0.60; 95% CI for IRR = [0.44, 0.81], p < .001). The mag-
nitude of risk reduction was not significantly different across 
clinical sites. Coronal caries incidence rates did not differ sig-
nificantly between participants in the xylitol and placebo arms 
(2.51 vs. 2.70 D2FS/yr; IRR = 0.93; 95% CI [0.83, 1.05], p = 
.242). Finally, the ‘treatment by surface type’ interaction in the 
unified coronal surfaces model was not significant (χ2 = 3.96, 
p = .138). We also compared the treatment effects across clinical 
sites and found no clinical site-specific effects.
DISCUSSION
Xylitol is a naturally occurring non-fermentable polyol used as 
a sugar substitute and is therefore considered a non-cariogenic 
sweetener (Maguire and Rugg-Gunn, 2003). Xylitol promotes 
remineralization by increasing salivary flow and inhibits bacte-
rial growth and metabolism in the plaque biofilm (Ly et al., 
2006; Milgrom et al., 2006; Söderling, 2009). Despite these 
favorable anti-cariogenic properties, the evidence for the clini-
cal effectiveness of xylitol as a caries-preventive agent is con-
troversial (Mäkinen, 1998; Scheie and Fejerskov, 1998). In 
addition, one recently published systematic review reported that 
the current evidence of the effect of xylitol for caries prevention 
contains high risk of bias and may be limited by confounder 
effects, suggesting that high-quality randomized trials are 
needed to evaluate xylitol’s effectiveness (Mickenautsch and 
Yengopal, 2012). Another recently published systematic review 
Table 1. Baseline Characteristics of X-ACT Trial Participants with at Least One Follow-up Visit and Complete Data on All Covariates
All Clinical Sites Xylitol n = 308 Placebo n = 312 Total n = 620
Mean age in yrs (SD) 46.4 (13.5) 48.1 (13.7) 47.3 (13.6)
Race/Ethnicity
 Non-Hispanic white 44.5% 50.6% 47.6%
 Non-Hispanic black 28.9% 25.0% 26.9%
 Hispanic 23.4% 21.2% 22.3%
 Other 2.9% 3.2% 3.1%
Female 62.3% 66.7% 64.5%
Brushes 2+ times/day1 63.0% 69.9% 66.5%
Flosses 1+ times/day2 47.7% 47.4% 47.6%
Dental visit in past year3 31.8% 31.7% 31.8%
Self-reported dry mouth4 5.2% 8.0% 6.6%
Extent of fluoride exposure5
Toothpaste or mouthwash fluoride 52.6% 61.5 % 57.1%
Both toothpaste and mouthwash fluoride 38.6% 31.1% 34.8%
1Percentage of participants who self-reported brushing at least twice per day.
2Percentage of participants who self-reported flossing at least once per day.
3Percentage of participants who self-reported having had a routine dental visit for a dental examination or a dental cleaning in the year before 
the baseline study visit.
4Percentage of participants who self-reported dry mouth when eating or constantly.
5Percentages of participants who self-reported regularly using over-the-counter fluoridated toothpaste or mouthwash, or both, after brushing.
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suggests that xylitol could have tooth-surface-specific caries-
preventive effects (Antonio et al., 2011) but did not examine 
coronal vs. root surfaces. Furthermore, most evidence of xylitol 
for caries prevention is derived from studies on children and 
adolescents with no root surfaces at risk.
X-ACT was designed and conducted as a highly controlled 
randomized clinical trial to test the effectiveness of xylitol in 
preventing caries in adults. The placebo lozenge used in the trial 
was sweetened with sucralose, which lacks any plausible bio-
logic cariostatic or cariogenic properties (Mandel and Grotz, 
2002). Bader et al. (2013) found that daily consumption of 3 to 
5 grams of xylitol in lozenges reduced the overall (coronal and 
root) caries increment by 11%, which was not statistically sig-
nificant when compared with placebo use. However, when tooth 
surfaces were analyzed separately as in the current analysis, 
xylitol lozenges had a statistically significant caries-preventive 
effect on root surfaces, though not on coronal surfaces.
These results have important implications for root caries 
prevention and management and are consistent with previous 
reports of xylitol preventive effects on root surfaces (Mäkinen 
et al., 1995, 1996; Deshpande and Jadad, 2008). Although coro-
nal caries is more prevalent than root caries, root caries is an 
increasingly important clinical problem in dentistry, with an 
annual incidence of 27% among older adults (Griffin et al., 
2004; Ritter et al., 2010). Nonetheless, little research emphasis 
is given to preventing caries in adults and, specifically, to pre-
venting root caries. A recent randomized clinical trial on root 
caries prevention in elders showed that oral hygiene instruction 
alone is less effective in preventing root caries than when pre-
ventive agents such as chlorhexidine varnish, sodium fluoride 
varnish, and silver diamine fluoride solution were used (Tan 
et al., 2010). While fluoride agents have been shown to be mod-
erately effective in the prevention of root caries (Jensen and 
Kohout, 1988; Ekstrand et al., 2008), there is continuing interest 
in the study of alternative low-risk and low-cost anticaries 
agents (ten Cate, 2012; Walls and Meurman, 2012).
The results of this secondary analysis indicate that xylitol 
appears to be effective for root surface caries, but less so for 
coronal surface caries. There are several plausible explanations 
for this root-surface-specific effect. First, it is possible that there 
might be differences in composition/virulence between root and 
coronal biofilms (Sansone et al., 1993; Aamdal-Scheie et al., 
1996; Huang et al., 2011), hence modifying the susceptibility of 
these substrates to xylitol effects and caries development. 
Supporting this hypothesis, it has been shown that some strains 
of oral bacteria are more sensitive to xylitol’s inhibitory effect 
than others (Söderling, 2009). Second, anatomic factors render 
root surfaces more prone to biofilm stagnation and plaque build-
up, and xylitol may have a more pronounced effect in areas with 
stagnant biofilm such as root surfaces. This hypothesis is sup-
ported to some extent by the results of this analysis on the vari-
ous coronal surfaces, i.e., xylitol appears to be more effective 
(although non-significantly) on smooth than on occlusal coronal 
surfaces. Third, it is known that the critical pH for dentin demin-
eralization is higher than that for enamel demineralization 
(Featherstone, 2004). Because root surface caries is mostly a 
dentin caries phenomenon (as opposed to coronal enamel car-
ies), it is plausible that xylitol exerts a higher caries-preventive 
effect at the pH range of dentin demineralization than that of 
enamel. However, it should be noted that the critical pH is not a 
constant, since the levels of calcium and phosphate in the bio-
film fluid vary among individuals (Dawes, 2003).
Although we observed a significant preventive effect on root 
surfaces, these results are limited by the relatively small number 
of participants with root caries, given that approximately 70% of 
the root surfaces either were not at risk or had no disease. 
However, the observed root caries incidence is consistent with 
previously reported data (Griffin et al., 2004), considering that 
this was a high-risk population. The overall root caries (D2FS) 
33-month incidence in the sample was 29.52% (24.03% in the 
xylitol arm, 34.94% in the placebo arm). As noted above, the 
mean age for participants in this study was 47 yrs. An older 
population would likely yield more representative results rela-
tive to root caries prevention. Another consideration is that, as 
reported above, all participants lived in communities with fluo-
ridated water, and many used home care fluoride products 
(Table 1). Therefore, xylitol was an add-on intervention, and any 
interpretation of the observed results should take that into 
account. Finally, while the xylitol dosage used in X-CT was 
considered adequate when the trial was designed, more recent 




n = 312 IRR2 95% CI3 p
Type of surface  
Root 0.234 0.38 0.60 [0.44, 0.81] < .001
Coronal 2.51 2.70 0.93 [0.83, 1.05]  .242
Type of coronal surface
Smooth 1.06 1.19 0.89 [0.77, 1.02] .100
Occlusal 0.38 0.35 1.09 [0.89, 1.34] .408
Proximal 0.94 1.05 0.90 [0.77, 1.04] .159
1Zero-inflated negative binomial regression was used for modeling root caries increment; the logistic part of the model did not include treatment, 
or brushing/flossing habits, the latter omitted due to convergence issues.
2Incidence Rate Ratio.
3Confidence Interval.
4Model-based annualized means adjusted for clinical site, age, age-squared, dental visit history, over-the-counter fluoride use, oral hygiene prac-
tices, and severity of baseline caries (D2FS).
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information suggests that the 5 gm/day dose may fall below a 
therapeutic threshold (Milgrom et al., 2009).
While the root-caries-preventive effect observed in this study 
was statistically significant (40% less root surface caries/yr), the 
magnitude of the risk reduction effect (0.15 surface/yr) was 
clinically modest. In light of the fact that this was a secondary 
analysis of the data, and the study’s primary outcome analysis 
was not statistically significant (Bader et al., 2013), these results 
should be viewed with caution. Nonetheless, we believe that 
these results, combined with those of previous studies, support 
the clinical recommendation that patients use xylitol lozenges 
– given their low cost, low risk, and ease of use – to help prevent 
root caries.
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